farnesol - CISMeF

Preferred Label : farnesol;

MeSH definition : A colorless liquid extracted from oils of plants such as citronella, neroli, cyclamen, and tuberose. It is an intermediate step in the biological synthesis of cholesterol from mevalonic acid in vertebrates. It has a delicate odor and is used in perfumery. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed);

MeSH CAS label : 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-;

Registry Number MeSH : 4602-84-0;

Wikipedia link : https://en.wikipedia.org/wiki/Farnesol;

Codes EINECS : 225-004-1;

Is substance : O;

Details

Origin ID

D005204;

UMLS CUI

C0015637;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- farnesol [Substance BNPC]
Currated CISMeF NLP mapping
- Farnesol [ICD-11 Extension code]
- Farnesol (substance) [SNOMED CT concept]
- Farnesol, (2E,6E)- [NCIt concept]
Record concept(s)
- farnesol [MeSH concept]
Related MeSH Supplementary Concept(s)
- (alpha-hydroxyfarnesyl)phosphonic acid [MeSH Supplementary Concept]
- 2,3-dihydrofarnesol [MeSH Supplementary Concept]
- 2,3-dihydrohomofarnesal [MeSH Supplementary Concept]
- 3-(phenylsulfonyl)-4-(4-(1-(2-(3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoyl)pyrrolidine-2-carbonyloxy)but-2-ynyloxy)-1,2,5-oxadiazole-2-oxide [MeSH Supplementary Concept]
- 3-farnesyl-2-hydroxybenzoic acid [MeSH Supplementary Concept]
- 3-hydroxy-2,3-dihydrofarnesal [MeSH Supplementary Concept]
- 7-demethylfarnesyl pyrophosphate [MeSH Supplementary Concept]
- N-homogeranyl-N-methyl-N'-farnesylformamidine [MeSH Supplementary Concept]
- cyclopren [MeSH Supplementary Concept]
- deacetoxyyanuthone A [MeSH Supplementary Concept]
- epoxyfarnesyl diazoacetate [MeSH Supplementary Concept]
- epoxyhomofarnesyl diazoacetate [MeSH Supplementary Concept]
- farnesal [MeSH Supplementary Concept]
- farnesyl anthranilate [MeSH Supplementary Concept]
- farnesyl diazomethyl ketone [MeSH Supplementary Concept]
- farnesyl methyl ether [MeSH Supplementary Concept]
- farnesyl-O-acetylhydroquinone [MeSH Supplementary Concept]
- farnesylacetic acid [MeSH Supplementary Concept]
- farnesylamine [MeSH Supplementary Concept]
- farnesylthioacetic acid [MeSH Supplementary Concept]
- farnesylthiosalicylic acid [MeSH Supplementary Concept]
- farnesylthiotriazole [MeSH Supplementary Concept]
- mal-farnesol [MeSH Supplementary Concept]
- prednisolone farnesylate [MeSH Supplementary Concept]
- suc-farnesol [MeSH Supplementary Concept]
- transfarnesol [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Farnesol (substance) [SNOMED CT concept]
- Farnesol, (2E,6E)- [NCIt concept]
- farnesol [Substance BNPC]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients